Matches in Wikidata for { <http://www.wikidata.org/entity/Q91361610> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q91361610 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91361610 description "im November 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91361610 description "scientific article published on 21 November 2019" @default.
- Q91361610 description "wetenschappelijk artikel" @default.
- Q91361610 description "наукова стаття, опублікована 21 листопада 2019" @default.
- Q91361610 description "գիտական հոդված հրատարակված 2019 թվականի նոյեմբերի 21-ին" @default.
- Q91361610 name "Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial" @default.
- Q91361610 name "Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial" @default.
- Q91361610 type Item @default.
- Q91361610 label "Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial" @default.
- Q91361610 label "Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial" @default.
- Q91361610 prefLabel "Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial" @default.
- Q91361610 prefLabel "Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial" @default.
- Q91361610 P1433 Q91361610-3AF8F2DD-AFD8-487B-85EB-4EFEF6EF76B8 @default.
- Q91361610 P1476 Q91361610-A6D399C3-524B-448F-9A68-4592FF2A2CB5 @default.
- Q91361610 P2093 Q91361610-02B7A7A4-0968-4039-8B35-5F7316B726F4 @default.
- Q91361610 P2093 Q91361610-0317E60B-E0C8-40B7-9A6B-367E16C5D594 @default.
- Q91361610 P2093 Q91361610-4C689D6B-79CE-4C68-8C0B-44DA2338150A @default.
- Q91361610 P2093 Q91361610-68659E39-0E00-4C93-BFEA-6BAA6EDD0F90 @default.
- Q91361610 P2093 Q91361610-923A733C-C5F0-4F2E-A90B-0FF5560C3701 @default.
- Q91361610 P2093 Q91361610-9566F374-9FC1-4F5F-92A4-CD8E322964DD @default.
- Q91361610 P2093 Q91361610-D9C94E0E-7E61-4E2A-858F-1B04C886EFF7 @default.
- Q91361610 P31 Q91361610-C54ACB7F-F886-4BCD-BB6C-2E543F5E5282 @default.
- Q91361610 P356 Q91361610-2CC1F03D-ADCD-42D5-9452-B72BF7434579 @default.
- Q91361610 P577 Q91361610-64878C5F-9003-47AC-BE86-4DA044EC1DAD @default.
- Q91361610 P698 Q91361610-B039E3E1-65F9-4587-92AE-0927BEFEACD0 @default.
- Q91361610 P921 Q91361610-3FB40467-3CB1-46CA-BB1D-446441159D27 @default.
- Q91361610 P356 JAT.50963 @default.
- Q91361610 P698 31748467 @default.
- Q91361610 P1433 Q26842628 @default.
- Q91361610 P1476 "Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial" @default.
- Q91361610 P2093 "Chen Lu" @default.
- Q91361610 P2093 "Hyoe Inomata" @default.
- Q91361610 P2093 "Ikuo Inoue" @default.
- Q91361610 P2093 "Junichiro Shimauchi" @default.
- Q91361610 P2093 "Kouji Kajinami" @default.
- Q91361610 P2093 "Marcoli Cyrille" @default.
- Q91361610 P2093 "Shinji Koba" @default.
- Q91361610 P31 Q13442814 @default.
- Q91361610 P356 "10.5551/JAT.50963" @default.
- Q91361610 P577 "2019-11-21T00:00:00Z" @default.
- Q91361610 P698 "31748467" @default.
- Q91361610 P921 Q42824827 @default.